Trials / Conditions / Stage III Uterine Corpus Leiomyosarcoma AJCC v8
Stage III Uterine Corpus Leiomyosarcoma AJCC v8
4 registered clinical trials studyying Stage III Uterine Corpus Leiomyosarcoma AJCC v8.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has NCT05432791 | National Cancer Institute (NCI) | Phase 2 / Phase 3 |
| Active Not Recruiting | Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tis NCT04200443 | City of Hope Medical Center | Phase 2 |
| Active Not Recruiting | A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advance NCT03880019 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma NCT02601209 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |